LiveL&T Construction receives Rs.8,650 crore order
L&T Construction has received an order worth Rs.8,650 crore, from Mumbai Metropolitan Region Development Authority (MMRDA). The order is for construction of Mumbai Trans Harbour Link (MTHL), packages...
Category : Latest News
Yes Bank, IndusInd bank will substitute Cipla, Lupin in BSE Sensex
Asia Index today stated that, IndusInd Bank and Yes Bank will enter into the BSE’s benchmark index from December 18, 2017, while Cipla and Lupin...
Anand Rajeshwar Baiwar takes charge as executive director of Sebi
Anand Rajeshwar Baiwar, has taken charge as an executive director of the Securities and Exchange Board of India (SEBI). Sebi in a release stated, “He...
Infosys to open buyback offer on November 30
Infosys will open its Rs.13,000 crore share buyback offer on November 30 and end it on December 14. This, is the first time in the...
Reliance General Insurance enters into bancassurance pact with Yes Bank
Reliance General Insurance Company Limited (RGI), a subsidiary of Reliance Capital, has entered into a comprehensive Bancassurance – Corporate Agency agreement with Yes Bank. The...
Allahabad Bank to sell Rs.101 cr Khaitan Electricals debt
Allahabad Bank will put on sale bad loans worth Rs.101 crore of Khaitan Electricals Ltd (KEL). The bank has scheduled e-auction for the sale of the loan on...
Kuwait’s Jazeera Airways launches India operations
Kuwait based Jazeera Airways has today launched its operations in India, with a flight daily between Kuwait and Hyderabad. As per Rohit Ramachandran, CEO of Jazeera,...
Toyota, Suzuki concludes MoU to introduce electric vehicles in India
Toyota Motor Corporation and Suzuki Motor Corporation have concluded a Memorandum of understanding (MoU), to introduce electric vehicles in India around 2020. According to the agreement,...
Lexus showcases its fourth model in India, the NX 300h
Lexus has today showcased its fourth model in India, the NX 300h. The Lexus NX 300h is a compact SUV and the company’s smallest model sold...
Cipla receives final approval for anti-asthma product from USFDA
US health regulator has given final approval to Cipla, for a suspension product used for treating asthma. Cipla in a BSE filing today stated, “it...